CD8A and B-cell chronic lymphocytic leukemia: BNT162b2 mRNA vaccine-induced Spike antigen-specific CD8+ T cells were detected in a substantial fraction of CLL and MDS patients already between days 7-10 after the first dose of vaccination (TP1).